Evidence map›Paper›PMID 26076995›Full record

ArticleMedical science monitor basic research2015

Use of X-Chromosome Inactivation Pattern to Analyze the Clonality of 14 Female Cases of Kaposi Sarcoma.

Ding Yuan, Wu XiuJuan, Zhang Yan, Liang JunQin, Xiang Fang, Yu Shirong, Kang Xiaojing, Feng Yanyan, Wu Weidong, Luo Dong and 3 more

Abstract read
In one paragraph

Article in Medical science monitor basic research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Ding YuanDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Wu XiuJuanDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Zhang YanDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Liang JunQinDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Xiang FangDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Yu ShirongDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Kang XiaojingDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Feng YanyanDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Wu WeidongDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Luo DongDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Lu QingliDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Zhang DeZhiDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
Pu XiongMingDepartment of Dermatology and Venereology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (mainland).
People's Hospital of Xinjiang Uygur Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKaposi sarcoma (KS) has features of both neoplastic growth and hyperplastic proliferation. It is the most common tumor seen in patients with HIV infection. Whether KS is a real tumor or a benign hyperplastic disease is not known. MATERIAL AND

methodsTissues from KS and cutaneous hemangioma lesion DNA were extracted, and then digested with methylation-sensitive restriction endonuclease HpaII. Human androgen receptor gene (HUMARA) was amplified with PCR method and the product was separated on 10% denaturing polyacrylamide gels and stained with ethylene dibromide (EB) to show the polymorphism of HUMARA. Phosphoglycerate kinase (PGK) was amplified and the product was digested by BStXI, agarose gel and EB stained to show the polymorphism of PGK. Finally, we analyzed the clonality of KS.

resultsIn the 14 patients with KS, heterozygosity of the HUMARA gene was observed in 12 (85.7%) cases. Loss of heterozygosity of HUMARA gene on X-chromosome (without HpaII digestion there were 2 bands, after HpaII digestion there were just 1 of the bands), representing monoclonal origin, was present in 11 cases of Kaposi sarcoma. Heterozygosity of the PGK gene was observed in 5 (35.7%) cases, which all represent monoclonal origin. There was no significant difference according to country, stage, or HIV and HHV-8 (P>0.05).

conclusionsThe current findings suggest that Kaposi sarcoma is a clonal neoplasm, not a reactive proliferation.

Indexed as

Polymorphism, GeneticDNA PrimersFemaleHIV InfectionsHumansImmunohistochemistryLoss of HeterozygosityNucleic Acid Amplification TechniquesPhosphoglycerate KinaseReceptors, AndrogenSarcoma, KaposiX Chromosome InactivationAR protein, humanDNA PrimersPhosphoglycerate KinaseReceptors, Androgen

Identifiers

PMID26076995
PMCPMC4482332
OpenAlexW1484839518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.